Hegazy Mohamed A F, Kotb Sherif Z, Sakr Hanem, El Dosoky Ebrahim, Amer Talal, Hegazi Refaat A F, Farouk Omar
Department of Surgical Oncology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Ann Surg Oncol. 2007 Feb;14(2):568-76. doi: 10.1245/s10434-006-9138-1. Epub 2006 Nov 9.
At present, limb-sparing surgery is the most appropriate and acceptable treatment option for soft tissue sarcomas of the extremities. To increase the number of limb-sparing resections in the treatment of locally advanced soft tissue sarcomas of the extremities, preoperative radiotherapy and/or chemotherapy are often used. Isolated limb perfusion of cytostatic agents is an effective alternative option but technically complex. Isolated limb infusion, essentially a low-flow isolated limb perfusion without oxygenation via a percutaneous catheter, had been developed as a simple alternative.
The objective of this study was to achieve limb-sparing surgery in patients with locally advanced soft tissue sarcomas of the extremities that would otherwise have required an amputation or a functionally mutilating surgery by performing preoperative isolated limb infusion with doxorubicin and external beam irradiation to obtain local control and make limb-sparing surgery feasible.
A total of 40 patients with locally advanced soft tissue sarcomas of the extremities were evaluated between 2002 and 2005. Tumors were located in the lower limb in 28 patients (70%) and in the upper limb in 12 patients (30%). All of these patients were felt to be unresectable and were referred because amputation was considered the only available treatment option. They underwent preoperative isolated limb infusion with doxorubicin (0.7 and 1.4 mg/kg for the upper and lower limbs, respectively). Preoperative external beam radiotherapy started within 3-7 days after isolated limb infusion was administered. The total dose was 35 Gy in ten fractions. After 3-7 weeks, surgery was performed aiming at limb preservation.
Tumor response was seen in 85% of patients, rendering these large sarcomas resectable in most cases. The mean values of pretreatment tumor volume and post-treatment volume were 2797 cm(3) and 1781 cm(3), respectively, with a significant p value of 0.0001. Histologic response was seen in 80% of patients. At a median followup of 15 months (range = 5-35), limb salvage was achieved in 82.5%. Procedure-related complications were limited and easily managed.
Isolated limb infusion with doxorubicin is a simple and safe method of regional chemotherapy. The addition of preoperative external beam irradiation helped to increase the rate of limb salvage in patients with large and/or high-grade soft tissue sarcomas of the extremities.
目前,保肢手术是治疗四肢软组织肉瘤最合适且可接受的治疗选择。为了增加四肢局部晚期软组织肉瘤保肢切除的数量,术前常采用放疗和/或化疗。局部灌注细胞毒性药物是一种有效的替代选择,但技术复杂。局部灌注化疗,本质上是一种通过经皮导管进行的低流量、无氧合的局部灌注化疗,已被开发为一种简单的替代方法。
本研究的目的是通过对局部晚期四肢软组织肉瘤患者进行术前多柔比星局部灌注化疗和外照射,以实现保肢手术,否则这些患者将需要截肢或进行功能性致残手术,从而获得局部控制并使保肢手术可行。
2002年至2005年期间,共评估了40例局部晚期四肢软组织肉瘤患者。28例(70%)肿瘤位于下肢,12例(30%)位于上肢。所有这些患者均被认为无法切除,因截肢被视为唯一可行的治疗选择而被转诊。他们接受了术前多柔比星局部灌注化疗(上肢和下肢分别为0.7和1.4mg/kg)。术前外照射在局部灌注化疗后3 - 7天内开始。总剂量为35Gy,分10次给予。3 - 7周后,进行旨在保肢的手术。
85%的患者出现肿瘤反应,使得这些大的肉瘤在大多数情况下可切除。治疗前肿瘤体积和治疗后体积的平均值分别为2797cm³和1781cm³,p值显著,为0.0001。80%的患者出现组织学反应。中位随访15个月(范围5 - 35个月)时,保肢率达82.5%。与手术相关的并发症有限且易于处理。
多柔比星局部灌注化疗是一种简单安全的区域化疗方法。术前增加外照射有助于提高四肢大的和/或高级别软组织肉瘤患者的保肢率。